Found: 2
Select item for more details and to access through your institution.
Results of a phase I trial with Haploidentical mbIL‐21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 890, doi. 10.1002/ajh.27281
- By:
- Publication type:
- Article
Natural killer cells for antiviral therapy.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 677, p. 1, doi. 10.1126/scitranslmed.abl5278
- By:
- Publication type:
- Article